$20 million incoming Q4
dont know why news has not been widely distributed. Middle of March they pre announced in excess of $20 million Q4 and $54 million on the year. Have also released news about closing all previous transactions along with Israel medical board approval for the pharmacy acquisition. Should set up well if there is a return of better sentiment in the rest of the sector. I'll just continue to buy waiting on the big news out of Germany. Earnings call is listed for tomorrow but year end wont come out until end of April.